A detailed history of Citigroup Inc transactions in Orasure Technologies Inc stock. As of the latest transaction made, Citigroup Inc holds 118,606 shares of OSUR stock, worth $440,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,606
Previous 81,444 45.63%
Holding current value
$440,028
Previous $346,000 46.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.93 - $4.59 $146,046 - $170,573
37,162 Added 45.63%
118,606 $506,000
Q2 2024

Aug 12, 2024

SELL
$4.2 - $6.18 $131,565 - $193,588
-31,325 Reduced 27.78%
81,444 $346,000
Q1 2024

May 10, 2024

BUY
$6.08 - $8.28 $420,200 - $572,247
69,112 Added 158.31%
112,769 $693,000
Q4 2023

Feb 09, 2024

BUY
$5.13 - $8.35 $78,576 - $127,896
15,317 Added 54.05%
43,657 $357,000
Q3 2023

Nov 09, 2023

SELL
$4.4 - $6.91 $113,634 - $178,457
-25,826 Reduced 47.68%
28,340 $168,000
Q2 2023

Aug 10, 2023

BUY
$4.88 - $7.39 $104,758 - $158,641
21,467 Added 65.65%
54,166 $271,000
Q1 2023

May 11, 2023

SELL
$4.66 - $6.52 $49,740 - $69,594
-10,674 Reduced 24.61%
32,699 $197,000
Q4 2022

Feb 09, 2023

SELL
$3.7 - $5.29 $3,896 - $5,570
-1,053 Reduced 2.37%
43,373 $209,000
Q3 2022

Nov 10, 2022

BUY
$2.72 - $4.61 $6,005 - $10,178
2,208 Added 5.23%
44,426 $168,000
Q2 2022

Aug 10, 2022

SELL
$2.71 - $7.12 $109,196 - $286,893
-40,294 Reduced 48.83%
42,218 $114,000
Q1 2022

May 12, 2022

BUY
$6.62 - $9.33 $47,021 - $66,270
7,103 Added 9.42%
82,512 $559,000
Q4 2021

Feb 10, 2022

BUY
$8.3 - $11.29 $309,614 - $421,150
37,303 Added 97.89%
75,409 $656,000
Q3 2021

Nov 10, 2021

BUY
$9.73 - $13.38 $370,771 - $509,858
38,106 New
38,106 $431,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $269M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.